Clinical Trials Browser

OTHER × Multiple Myeloma × Biological Products × Clear all

NCT02128230 2021-06-22

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Phase 2 Terminated

20 enrolled 7 charts

Multiple Myeloma